This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Remy Muts
PhD Candidate at UMC Utrecht
Speaker

Profile

Remy Muts is a final stage PhD candidate in the Group of Suzan Rooijakkers at the Medical Microbiology department of the UMC Utrecht in The Netherlands. His projects focus on investigating how IgM antibodies compare to IgG in driving effector functions, with the main focus being on the complement system and how it kills and opsonises bacteria. To study this, new monoclonal antibodies are required which the research group either acquires through single cell sorting healthy or patient-derived B cells, or by engineering bacteria to express an antigen of choice.

Agenda Sessions

  • Converting IgG to IgM to Target Infectious Disease

    11:30am